Australia's traditional approach to HTA has relied on decisions based on large amounts of data and evidence at the time of initial funding evaluation - something that simply will not be available in the era of personalised medicine.
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 24 April
April 24, 2026 - - Podcast -
Prevention warning as Pfizer urges Budget reset on vaccines and immunisation
April 24, 2026 - -
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 - - Latest News -
Boehringer Ingelheim and Heart of Australia take mobile lung care deeper into regional Australia
April 24, 2026 - - Latest News -
A decade to diagnosis highlights hidden burden of immune disorders
April 24, 2026 - - Latest News -
Quiet diplomacy as Australia navigates global pricing pressure, but can it work?
April 24, 2026 - - Latest News -
New immunotherapy option approved for Australians with relapsed follicular lymphoma
April 24, 2026 - - Latest News
